USD 0.76
(-1.22%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 2.95 Billion | 2.83 Billion | 3.58 Billion | 2.8 Billion | 2.02 Billion |
Cost of Revenue | 1.2 Billion | 556.92 Million | 557.17 Million | 430.77 Million | 292.49 Million |
Gross Profit | 1.74 Billion | 2.28 Billion | 3.02 Billion | 2.37 Billion | 1.72 Billion |
Operating Expenses | 1.75 Billion | 2.9 Billion | 3.13 Billion | 2.24 Billion | 1.49 Billion |
Selling, General and Administrative Expenses | 1.63 Billion | 2.82 Billion | 3.06 Billion | 2.2 Billion | 1.44 Billion |
Research and Development Expenses | 91.46 Million | 90.65 Million | 93.88 Million | 70.93 Million | 65.47 Million |
Other Expenses | 25.82 Million | -12.87 Million | -26.61 Million | -24.79 Million | -12.34 Million |
Cost and Expenses | 2.95 Billion | 3.45 Billion | 3.69 Billion | 2.67 Billion | 1.79 Billion |
Operating Income | -1.06 Million | -621.24 Million | -108.99 Million | 131.83 Million | 232.06 Million |
Interest Expense | 4.22 Million | 31.28 Million | 38.05 Million | 40.62 Million | 26.96 Million |
Income Tax Expense | 21.02 Million | 114.47 Million | -359.04 Million | 18.56 Million | 45.83 Million |
Earnings before Tax | 108.76 Million | -596.76 Million | -124.61 Million | 93.99 Million | 212.43 Million |
Net Income | 87.74 Million | -711.24 Million | 234.43 Million | 75.42 Million | 166.6 Million |
Earnings Per Share Basic | 0.34 | -2.74 | 1.15 | 2.77 | 6.11 |
Earnings Per Share Diluted | 0.34 | -2.74 | 1.15 | 2.77 | 6.11 |
Weighted Average Shares Outstanding | 260.03 Million | 259.15 Million | 203.28 Million | 27.25 Million | 27.25 Million |
Weighted Average Shares Outstanding (Diluted) | 260.03 Million | 259.4 Million | 203.28 Million | 27.25 Million | 27.25 Million |
Gross Margin | 0.59 | 0.80 | 0.84 | 0.85 | 0.86 |
EBIT Margin | 0.13 | -0.20 | -0.02 | 0.17 | 0.22 |
Profit Margin | 0.03 | -0.25 | 0.07 | 0.03 | 0.08 |
EBITDA | 388.29 Million | -116.42 Million | 310.34 Million | 478 Million | 433.55 Million |
Earnings Before Tax Margin | -0.00 | -0.22 | -0.03 | 0.05 | 0.11 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 462.92 Million | 397.2 Million | 486.62 Million | 2.95 Billion | 613.46 Million | 1.03 Billion |
Cost of Revenue | 219.6 Million | 167.73 Million | 198.71 Million | 1.2 Billion | 214.81 Million | 668.54 Million |
Gross Profit | 243.32 Million | 229.46 Million | 287.9 Million | 1.74 Billion | 398.64 Million | 367.17 Million |
Operating Expenses | 249.34 Million | 252.22 Million | 320.76 Million | 1.75 Billion | 364.64 Million | 353.62 Million |
Selling, General and Administrative Expenses | 220.39 Million | 231.07 Million | 279.33 Million | - | 335.31 Million | 326.26 Million |
Research and Development Expenses | 20.81 Million | 19.67 Million | 27.56 Million | - | 23.79 Million | 18.65 Million |
Other Expenses | -5000.00 | 73 Thousand | 90 Thousand | 63 Thousand | -16 Thousand | 172 Thousand |
Cost and Expenses | 468.94 Million | 419.96 Million | 519.47 Million | 2.95 Billion | 579.45 Million | 1.02 Billion |
Operating Income | -6.02 Million | -22.75 Million | -32.85 Million | -1.06 Million | 34 Million | 13.55 Million |
Interest Expense | - | - | - | 4.22 Million | - | - |
Income Tax Expense | 11.01 Million | 7.68 Million | 579 Thousand | 21.02 Million | 20.44 Million | -28.05 Million |
Earnings before Tax | 20.19 Million | 7.33 Million | 2.98 Million | 108.76 Million | 70.45 Million | 24.51 Million |
Net Income | 9.17 Million | -349 Thousand | 2.4 Million | 87.74 Million | 50 Million | 24.51 Million |
Earnings Per Share Basic | 0.00 | -0.00 | 0.01 | - | 0.20 | 0.10 |
Earnings Per Share Diluted | 0.00 | -0.00 | 0.01 | - | 0.20 | 0.10 |
Weighted Average Shares Outstanding | 256.62 Million | 259.24 Million | 260.03 Million | 260.03 Million | 260.03 Million | 260.02 Million |
Weighted Average Shares Outstanding (Diluted) | 261.72 Million | 259.24 Million | 260.03 Million | 260.03 Million | 260.03 Million | 260.02 Million |
Gross Margin | 0.53 | 0.58 | 0.59 | 0.59 | 0.65 | 0.35 |
EBIT Margin | 0.05 | 0.02 | -0.00 | - | 0.11 | 0.04 |
Profit Margin | 0.02 | -0.00 | 0.00 | 0.03 | 0.08 | 0.02 |
EBITDA | 22.72 Million | 7.9 Million | -1.96 Million | - | 66.15 Million | 41.78 Million |
Earnings Before Tax Margin | -0.01 | -0.06 | -0.07 | -0.00 | 0.06 | 0.01 |
LAVV3
MEDS
600731
112040
9262
TODGF